Exclusive

Publication

Byline

Korea's SK pharmteco invests more than $200 M to expand small molecule and peptide capacity in US

Singapore, Oct. 6 -- SK pharmteco, a subsidiary of SK Inc., the strategic investment company for SK Group, South Korea's second-largest conglomerate, has announced a comprehensive five-year, more than... Read More


Vitalant launches cell-based analytics lab to support allogeneic therapy developers

Singapore, Oct. 6 -- Vitalant, one of the nation's largest nonprofit blood and biotherapies healthcare organisations, has announced the launch of its analytics lab at the Phoenix Bioscience Core, expa... Read More


Independent CGT manufacturers launch global alliance to support therapy scale-up

Singapore, Oct. 6 -- Cell and gene therapies may now be moving faster than the manufacturing networks built to deliver them. The Alliance of CGT Manufacturing Partners (ACGMP) is launching a global n... Read More


Germfree launches biopharmaceutical isolator for cell and gene therapy workflows

Singapore, Oct. 6 -- Germfree, a full-lifecycle engineering and manufacturing partner for mission-critical environments across life sciences, healthcare and biocontainment, has launched a new aseptic ... Read More


Terumo BCT partners TrAMPoline Pharma to automate TIL therapy manufacturing

Singapore, Oct. 6 -- Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company advancing blood- and cell-based therapies worldwide, has entered a research collaboration with TrAMPo... Read More


BioSpectrum Asia Announces Winners of 2026 Excellence Awards

Singapore, Oct. 5 -- BioSpectrum Asia, the region's leading life sciences media platform, is proud to announce the winners of the BioSpectrum Asia Excellence Awards 2026. As BioSpectrum Asia marks it... Read More


Eli Lilly launches 'Nujoom Al Ghad' to build next generation of Emirati talent in healthcare

Singapore, Oct. 5 -- Eli Lilly and Company (Lilly Gulf) has announced the launch of Nujoom Al Ghad, a new graduate programme designed to develop UAE national talent and create new career pathways into... Read More


Japanese startup Celaid Therapeutics completes second close of Series B financing round with $2.6 M

Singapore, Oct. 5 -- Japanese startup Celaid Therapeutics Inc. has announced the completion of the second close of its Series B financing round. The round welcomed Shionogi & Co., Ltd. and Teikoku Ven... Read More


Australia's CSL inks $1.2 B deal with Swiss firm Alentis to develop lixudebart for rare kidney and liver diseases treatment

Singapore, Oct. 5 -- Australia-based CSL and Swiss firm Alentis Therapeutics have entered into an exclusive global collaboration agreement to co-develop and co-promote lixudebart, which has the potent... Read More


ADB approves $43 M grant package for health security, primary healthcare reforms in Tajikistan

Singapore, Oct. 5 -- The Asian Development Bank (ADB) has approved a $43.27 million grant financing package to help Tajikistan build a more integrated health system that can better prevent, detect, an... Read More